Kinase inhibitors

Details for Australian Patent Application No. 2006309044 (hide)

Owner Eli Lilly and Company

Inventors Hudziak, Kevin John; Myers, Michael Ray; De Dios, Alfonso; Zhong, Boyu; Shih, Chuan; Blas De Blas, Jesus Andres; Bastian, Jolie Anne; Mader, Mary Margaret; Pobanz, Mark Andrew; Lopez De Uralde-Garmendia, Beatriz; Li, Tiechao

Agent Spruson & Ferguson

Pub. Number AU-B-2006309044

PCT Pub. Number WO2007/053394

Priority 60/731,604 28.10.05 US; 06380151.8 02.06.06 EP; 60/821,963 10.08.06 US

Filing date 25 October 2006

Wipo publication date 10 May 2007

Acceptance publication date 13 October 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/497 (2006.01)

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/053394 Priority application(s): WO2007/053394

13 October 2011 Application Accepted

  Published as AU-B-2006309044

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006309050-Piperidine glycine transporter inhibitors

2006309040-Methods for the use of branched chain amino acids